Any current/future new fundraising through debt or equity?

The transcript does not mention any current or planned fundraising through debt or equity. CAPEX plans for FY26 are projected at Rs. 250-300 crores, primarily for debottlenecking and capacity expansion. The company is focused on organic growth through capacity enhancements and process improvements. There is no indication of external financing to support these CAPEX investments mentioned in the transcript. Management emphasized confidence in sustaining growth and improving margins through operational efficiencies rather than external funding.

Any current/future capex/capital investment/strategic investment?

FY26 CAPEX planned at Rs. 250 to 300 crores, primarily for debottlenecking and expanding capacity by 6,000 metric tons. This expansion aims to increase total capacity from 48,000 to 54,000 metric tons, expected to complete by March 2026. Debottlenecking investments involve enhancing existing major product lines, not large-scale new setups, resulting in improved asset turnover. Additional CAPEX plans include investments to support growth rates of 20%-25% and development of new products in demand. Investment in JV "PRIGIV" started operations in Feb 2025, with expected breakeven around FY

Future growth expectations in sales/revenue/volumes?

Privi Speciality Chemicals aims to sustain a growth rate of 20% to 25% annually. Capacity expansion from 48,000 to 54,000 metric tons is expected to complete by March 2026, supporting volume growth. Debottlenecking exercises are underway to optimize current capacities and improve asset turnover. The company plans to add approximately 6,000 metric tons additional capacity with CAPEX of Rs.250-300 crores. Growth drivers include increased share of wallet from existing customers, addition of new customers, and expansion into new geographies. New premium products launched cater to high-va

Future growth expectations in earnings/operating earnings/profits/EPS?

Privi expects to sustain a strong growth rate of 20% to 25% annually going forward (Mahesh Babani, multiple mentions). EBITDA margins are targeted to remain above 20%, with Q4 FY25 margin at 23.5% seen as sustainable (Mahesh Babani, Sanjeev Patil). Profit after tax for FY25 grew substantially to Rs.185 crores from Rs.95 crores in FY24, indicating improving profitability. The debottlenecking and capacity expansion (from 48,000 to 54,000 metric tons by March 2026) is expected to support volume and revenue growth (Narayan S. Iyer). The PRIGIV JV is expected to break even around FY27 and grow reve

Current/ Expected Orderbook/ Pending Orders?

The company is confident about its growth based on a strong order book position. Currently, it has expanded its customer base from 3 key customers to 6 key customers, including most of the top 10 companies. There are additional new customers, including five significant clients from regions like Africa, showing increasing demand. Orders are closely aligned with customer requirements, with new products introduced based on client demand. The management expects steady growth with ongoing commitments from these customers. The order book strength underpins the company’s confidence in sustaining 20%-

Privi Speciality Chemicals LtdQ1 FY26Chemicals & Petrochemicals

Privi Speciality Chemicals Ltd Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹3,462P/E: 40.7Market Cap: ₹14.3K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→Privi Speciality Chemicals aims to sustain a growth rate of 20% to 25% annually.
→Capacity expansion from 48,000 to 54,000 metric tons is expected to complete by March 2026, supporting volume growth.
→Debottlenecking exercises are underway to optimize current capacities and improve asset turnover.
→The company plans to add approximately 6,000 metric tons additional capacity with CAPEX of Rs.250-300 crores.
→Growth drivers include increased share of wallet from existing customers, addition of new customers, and expansion into new geographies.
→New premium products launched cater to high-value markets, contributing to revenue expansion.
→PRIGIV JV is expected to break even around FY26-27 and grow steadily at 10%-15%.
→Product innovation, robust backward integration, and sustainability focus provide a competitive edge for future demand.
→Overall, optimistic about 20%+ growth in FY26, driven by volume, new products, and operational improvements.

Margin guidance

Category 3

→Privi expects to sustain a strong growth rate of 20% to 25% annually going forward (Mahesh Babani, multiple mentions).
→EBITDA margins are targeted to remain above 20%, with Q4 FY25 margin at 23.5% seen as sustainable (Mahesh Babani, Sanjeev Patil).
→Profit after tax for FY25 grew substantially to Rs.185 crores from Rs.95 crores in FY24, indicating improving profitability.
→The debottlenecking and capacity expansion (from 48,000 to 54,000 metric tons by March 2026) is expected to support volume and revenue growth (Narayan S. Iyer).
→The PRIGIV JV is expected to break even around FY27 and grow revenue steadily at 10%-15%, potentially reaching Rs.300-350 crores in 3-4 years, adding incremental earnings.
→Long-term confidence in growth is underpinned by strong product innovation, increased wallet share from customers, and expanding international markets.
→Overall, Privi targets sustained top-line growth with improving margins and return ratios leading to steady EPS growth.

3 more insights locked — sign up free to unlock

Fundraise plans

→The transcript does not mention any current or planned fundraising through debt or equity.
→CAPEX plans for FY26 are projected at Rs. 250-300 crores, primarily for debottlenecking and capacity expansion.
→The company is focused on organic growth through capacity enhancements and process improvements.
→There is no indication of external financing to support these CAPEX investments mentioned in the transcript.
→Management emphasized confidence in sustaining growth and improving margins through operational efficiencies rather than external funding.

Order book

Yes

→The company is confident about its growth based on a strong order book position.
→Currently, it has expanded its customer base from 3 key customers to 6 key customers, including most of the top 10 companies.
→There are additional new customers, including five significant clients from regions like Africa, showing increasing demand.
→Orders are closely aligned with customer requirements, with new products introduced based on client demand.
→The management expects steady growth with ongoing commitments from these customers.
→The order book strength underpins the company’s confidence in sustaining 20%-30% growth rates going forward.
→PRIGIV JV has started operations recently and is expected to break even around FY26-27, adding to future order inflow and revenue.
→Overall, the company foresees continued healthy demand and business from diversified international markets.

Capex plans

Yes

→FY26 CAPEX planned at Rs. 250 to 300 crores, primarily for debottlenecking and expanding capacity by 6,000 metric tons.
→This expansion aims to increase total capacity from 48,000 to 54,000 metric tons, expected to complete by March 2026.
→Debottlenecking investments involve enhancing existing major product lines, not large-scale new setups, resulting in improved asset turnover.
→Additional CAPEX plans include investments to support growth rates of 20%-25% and development of new products in demand.
→Investment in JV "PRIGIV" started operations in Feb 2025, with expected breakeven around FY27; it will contribute revenues and margins gradually.
→The company is also investing to enhance scientific capabilities, such as hardware, lab equipment, software, and hiring scientists, to support the transition from supplier to partner in core development.

How does Privi Speciality Chemicals Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Privi Speciality Chemicals Ltd

Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Privi Speciality Chemicals Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio